HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.

Abstract
Acquired pure megakaryocytic aplasia (APMA) is a rare disorder in the field of hematological diseases. We report the case of a patient with APMA treated with mycophenolate mofetil and review the literature associated with this. Until today, very few cases of APMA have been reported and the disease etiology still seems to be unclear. There have been no reported cases of treatment of APMA treated with mycophenolate mofetil.
AuthorsDeepti Bulchandani, Jagdish Nachnani, Robert Belt, Stuart Hinton
JournalAmerican journal of hematology (Am J Hematol) Vol. 82 Issue 7 Pg. 650-1 (Jul 2007) ISSN: 0361-8609 [Print] United States
PMID17301968 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Mycophenolic Acid
Topics
  • Aged
  • Bone Marrow Diseases (drug therapy, pathology)
  • Humans
  • Male
  • Megakaryocytes (drug effects, pathology)
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Platelet Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: